Congratulations to all the recipients of the latest round of project grant funding from the Canadian Institutes of Health Research (CIHR), and a special congratulations to Drs. Michel Aliani, Jon McGavock, and Dake Qi!
- Dr Michel Aliani received funding for his project “The capacity for dietary flaxseed to inhibit the metabolism of antihypertensive drugs” for $1,189,575 (five years)
- Dr. Jonathon McGavock received funding his project “Honoring Ourselves and the Land – Reducing inequities in trail use for First Nations and Métis people in urban centres in Manitoba” for $1,266,075 (five years)
- Dr. Dake Qi received funding for his project “TAAR1 in adipose tissue is a novel therapeutic target to combat atypical antipsychotics (AAPs)-induced metabolic dysfunction via downregulation of MIF” for $849,150 (five years)
See the full list and news article here!
What's New
All Articles
New iCARE research highlights kidney health in youth with type 2 diabetes
A new study from the iCARE cohort examined kidney health over two years in 188 youth living with type 2…
Canadian Lipid and Vascular Summit 2026
DREAM co-lead Dr. Vern Dolinsky and PhD student Khushali Trivedi attended the Canadian Lipid and Vascular Summit last week in…
15th Annual DREAM Symposium and DREAM Trainee Day
The DREAM theme is excited to announce the 2026 DREAM Diabetes Research Symposium: New Perspectives in Diabetes will be held…
Now Recruiting Participants for a Research Study!
The Type 1 Diabetes Exercise and Mentorship (TEAM) Trial is recruiting teenagers living with type 1 diabetes in the Winnipeg…
3 DREAM Researchers Receive Funding from 2026 CHRIM Operating Grants
Congratulations to Drs. Ayesha Saleem, Sukhpreet Tamana, and Jennifer Yamamoto who received close to $150,000 in funding from the 2026…
iCARE Study Reached Their Recruitment Target!
Congratulations to the iCARE team on hitting their recruitment target of 375 participants in Manitoba! Huge thank you to the…